Human Breast Adenocarcinoma Model

Noble Life Sciences has optimized a xenograft model of the triple negative MDA-MB-231-luciferase human breast adenocarcinoma in the NCG mouse. The triple immunodeficient NCG mouse has a very high take rate for MDA-MB-231 and is thus an ideal host for the in vivo propagation for these human tumor cells.